New York Life Investment Management LLC Has $943,000 Stock Holdings in Avantor, Inc. $AVTR

New York Life Investment Management LLC grew its position in shares of Avantor, Inc. (NYSE:AVTR) by 543.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 70,027 shares of the company’s stock after buying an additional 59,137 shares during the period. New York Life Investment Management LLC’s holdings in Avantor were worth $943,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of AVTR. Signaturefd LLC increased its position in Avantor by 19.8% during the first quarter. Signaturefd LLC now owns 5,470 shares of the company’s stock worth $89,000 after acquiring an additional 904 shares during the period. Truist Financial Corp boosted its holdings in Avantor by 2.2% in the 2nd quarter. Truist Financial Corp now owns 44,325 shares of the company’s stock valued at $597,000 after purchasing an additional 959 shares during the period. Xponance Inc. grew its position in shares of Avantor by 0.9% during the 1st quarter. Xponance Inc. now owns 114,422 shares of the company’s stock worth $1,855,000 after purchasing an additional 966 shares in the last quarter. Louisiana State Employees Retirement System increased its holdings in shares of Avantor by 0.5% during the second quarter. Louisiana State Employees Retirement System now owns 191,700 shares of the company’s stock worth $2,580,000 after purchasing an additional 1,000 shares during the period. Finally, Nissay Asset Management Corp Japan ADV raised its position in shares of Avantor by 1.4% in the first quarter. Nissay Asset Management Corp Japan ADV now owns 83,661 shares of the company’s stock valued at $1,356,000 after buying an additional 1,138 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on AVTR. Raymond James Financial increased their price target on Avantor from $14.00 to $16.00 and gave the stock an “outperform” rating in a research report on Thursday, October 16th. Royal Bank Of Canada reduced their target price on Avantor from $20.00 to $17.00 and set an “outperform” rating on the stock in a report on Monday, August 4th. Evercore ISI decreased their price target on Avantor from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Thursday. UBS Group set a $12.00 price objective on shares of Avantor in a research report on Thursday. Finally, Robert W. Baird increased their price objective on shares of Avantor from $15.00 to $17.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Five investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $14.42.

Insider Activity at Avantor

In related news, Director Gregory L. Summe bought 100,000 shares of the firm’s stock in a transaction on Thursday, October 30th. The shares were purchased at an average price of $11.25 per share, with a total value of $1,125,000.00. Following the completion of the purchase, the director owned 300,000 shares in the company, valued at $3,375,000. This represents a 50.00% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CAO Steven W. Eck sold 3,476 shares of the company’s stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the transaction, the chief accounting officer owned 55,068 shares of the company’s stock, valued at $627,224.52. This trade represents a 5.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.20% of the company’s stock.

Avantor Price Performance

Avantor stock opened at $11.82 on Friday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.67 and a current ratio of 1.49. Avantor, Inc. has a 52 week low of $10.82 and a 52 week high of $23.70. The stock has a market capitalization of $8.06 billion, a P/E ratio of -90.89, a price-to-earnings-growth ratio of 4.08 and a beta of 0.98. The stock has a fifty day moving average of $13.33 and a 200-day moving average of $13.26.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, October 29th. The company reported $0.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.01). The business had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.65 billion. Avantor had a negative net margin of 1.25% and a positive return on equity of 10.91%. The business’s revenue was down 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.26 EPS. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. On average, sell-side analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.